International Clinical Trial: The Value of PD-1/PD-L1 in Assessing the Efficacy of Methotrexate Combined with Different Medications for Treating Rheumatoid Arthritis

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125039) titled 'The Value of PD-1/PD-L1 in Assessing the Efficacy of Methotrexate Combined with Different Medications for Treating Rheumatoid Arthritis' on May 20.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Affiliated Hospital of North Sichuan Medical College

Condition: rheumatoid arthritis

Intervention: Methotrexate combined with eramimod group:None Methotrexate combined with adalimumab group:None Methotrexate combined with tofacitinib group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-20

Target Sample Size: Methotrexate combined with eramimod g...